BRISC and BRCA1 A Complex Member 1 (BABAM1) Peptide
-
- Target See all BRISC and BRCA1 A Complex Member 1 (BABAM1) products
- BRISC and BRCA1 A Complex Member 1 (BABAM1)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DRAVGAQASV GSRSEGEGEA ASADDGSLNT SGAGPKSWQV PPPAPEVQIR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of C19 orf62 antibody,
Alternative Names: C19ORF62 control peptide, C19ORF62 antibody Blocking Peptide, Anti-C19ORF62 Blocking Peptide, FLJ20571 Blocking Peptide, HSPC142 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- BRISC and BRCA1 A Complex Member 1 (BABAM1)
- Synonyms
- merit40 Peptide, nba1 Peptide, zgc:100909 Peptide, c19orf62 Peptide, C19orf62 Peptide, MERIT40 Peptide, NBA1 Peptide, C7H19orf62 Peptide, 5430437P03Rik Peptide, Merit40 Peptide, BRISC and BRCA1 A complex member 1 Peptide, BRISC and BRCA1 A complex member 1 L homeolog Peptide, babam1 Peptide, BABAM1 Peptide, babam1.L Peptide, Babam1 Peptide
- Background
- C19orf62 is a component of the BRCA1-A complex, a complex that specifically recognises 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs).
- Molecular Weight
- 36 kDa
-